Both in Pharmaceuticals
Lipocine vs Lisata Therapeutics
Over the past year LPCN returned −45.7% and LSTA returned −61.8%; their daily moves had a correlation of -0.01.
LPCN −45.7% LSTA −61.8%Growth of $1, one year, split-adjusted
| Metric | LPCN | LSTA |
|---|---|---|
| Price | $1.44 | $1.02 |
| Market cap | $11.9M | $11.0M |
| Today | −5.26% | +0.99% |
| 1 month | −30.4% | −31.5% |
| 6 months | −38.2% | −67.4% |
| Year to date | −82.1% | −45.2% |
| 1 year | −46.5% | −61.7% |
| Revenue growth (YoY) | −100.0% | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 9.4× | 110.2× |
| Net cash | $23.3M | $10.4M |
| Dividend yield | — | — |
| Volatility (60d) | 57.4% | 116.7% |
| Short % of float | 4.6% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).